Most of the drug targets currently used and bioactive molecular in drug action are proteins.Proteomics provides an unbiased approach for the discovery of these molecular.However,there is bottleneck for the absence of a coherent verification linkage between the genome-wide discovery of bioactive molecular by proteomics and detailed one-by-one validation with traditional biochemical and biological methods.